Maintenance therapy for early loss of B-cell aplasia after CD19 CAR T-cell therapy-Reference-Cited by-同舟云学术

Maintenance therapy for early loss of B-cell aplasia after CD19 CAR T-cell therapy

Published:2023-10-11 Issue: Volume: Page:
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Gabelli Maria¹^ORCID,Oporto-Espuelas Macarena²,Bonney Denise Kathleen³,Burridge Saskia⁴,Farish Susan⁵,Mullanfiroze Khushnuma⁴,Lazareva Arina⁴,Samarasinghe Sujith⁶,Ancliff Philip⁴,Vora Ajay⁴,Bartram Jack⁵,Hedges Emma⁵,Ware Kirsty⁵,Young Lindsey⁵,Williams Lindsey⁴,Chu Jan⁴,Cugno Chiara⁷^ORCID,Chenchara Lenka⁷,Montibeller Furtado e Silva Juliana⁴,Mirci-Danicar Oana⁸,Riley Lynne⁵,Pavasovic Vesna⁵,Rao Anupama⁴,Lucchini Giovanna⁴,Chiesa Robert⁴,Rao Kanchan⁴,Shenton Geoff⁹,Hodby Katharine¹⁰,Alajangi Rajesh¹⁰,Jalowiec Katarzyna Aleksandra¹¹^ORCID,Hough Rachael E¹²,Amrolia Persis J.¹³^ORCID,Ghorashian Sara¹³^ORCID

Affiliation:

1. Università degli Studi di Padova, Italy

2. UCL Great Ormond Street Institute of Child Health, London, United Kingdom

3. Royal Manchester Children's Hospital, Manchester, United Kingdom

4. Great Ormond Street Hospital, London, United Kingdom

5. Great Ormond Street Hospital for children, London, United Kingdom

6. Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom

7. Sidra Medicine, Doha, Qatar

8. Bristol Royal Hospital for Children, Bristol, United Kingdom

9. Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, Newcastle upon Tyne, United Kingdom

10. University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

11. University College London Hospital, London, United Kingdom

12. UCLH, London, United Kingdom

13. Great Ormond Street Hospital for children, United Kingdom

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023011168/2084330/bloodadvances.2023011168.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia;British Journal of Haematology;2024-05-29

2. Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme;Blood Cancer Journal;2024-04-15

3. Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring;Frontiers in Immunology;2024-01-16